|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
5R21CA217137-02
|
$196,947
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
3R01CA215452-02S1
|
$7,156
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and Targeting Onocgenic MYC Enhancer Control in Pediatric Tumors
|
3R01CA215452-02S2
|
$45,800
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
5R01CA215452-02
|
$362,569
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Dissecting the molecular and functional role of ILK in driving metastatic colonization and progression in Ewing sarcoma
|
5R03CA215940-02
|
$75,288
|
YUSTEIN, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-05
|
$98,360
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Clinical Feasibility of Chemotherapy Monitoring for Sarcoma with Diffuse Optical Spectroscopic Imaging
|
1F31CA221074-01A1
|
$38,082
|
PETERSON, HANNAH
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Molecular Mechanisms Regulating the Alternative Lengthening of Telomeres Pathway
|
5R01CA201446-03
|
$377,438
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Functional characterization of the telomere repeat containing RNA, TERRA, in telomere maintenance
|
5R01CA214880-02
|
$237,158
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Developing a translational pipeline for NF1-mutant malignancies
|
5U01CA202943-03
|
$235,046
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of KSHV LANA
|
5R01CA082036-19
|
$228,408
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Determining the Epigenetic Mechanisms Driving Tissue Factor (F3) Upregulation and its Role in Metastatic Osteosarcoma
|
5F31CA213965-02
|
$44,524
|
BAYLES, IAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-28
|
$5,637,954
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-28S1
|
$249,965
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Contribution of Gynecologic and Breast Cancer Biospecimens from African American women to HCMI
|
3P30CA043703-28S2
|
$48,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeting VCAM1-a4b1 Signaling to Ameliorate Pulmonary Osteosarcoma Metastasis
|
5R21CA218790-02
|
$174,000
|
HUANG, ALEX
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Defining novel drivers and predictive signatures of metastasis in osteosarcoma th
|
5F30CA186633-05
|
$49,524
|
MORROW, JAMES
|
CASE WESTERN RESERVE UNIVERSITY
|
|
IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level
|
5R03CA219725-02
|
$80,000
|
PETROSIUTE, AGNE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Role of enhancer elements in regulating prometastatic transcriptional programs in osteosarcoma
|
5R01CA193677-03
|
$362,569
|
SCACHERI, PETER
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Investigation and functional characterization of new drivers of mesenchymal tumorigenesis.
|
4R00CA212200-03
|
$249,000
|
GUARNERIO, JLENIA
|
CEDARS-SINAI MEDICAL CENTER
|
|
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches
|
5R01CA200992-03
|
$363,125
|
KOEFFLER, HAROLD
|
CEDARS-SINAI MEDICAL CENTER
|
|
Cytokine- and Satellite Cell-mediated Muscle Disease Promotion
|
5R01CA189299-04
|
$338,550
|
KELLER, CHARLES
|
CHILDREN'S CANCER THERAPY DEVELOP/INST
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-05S1
|
$2,256,906
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-05
|
$192,024
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers
|
1U54CA232568-01
|
$12,197,183
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Early Stage Diagnosis of Kaposis Sarcoma in Limited Resource Settings using KS-Detect
|
4UH3CA202723-03
|
$993,475
|
ERICKSON, DAVID
|
CORNELL UNIVERSITY
|
|
Targeting FAK and integrin signaling in preclinical models of Ewing sarcoma
|
5K08CA188073-04
|
$177,120
|
CROMPTON, BRIAN
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S1
|
$445,796
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S2
|
$59,495
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S3
|
$62,500
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S4
|
$149,528
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S5
|
$60,691
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S6
|
$228,108
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-53S7
|
$199,806
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
5P30CA006516-53
|
$11,504,298
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
The Center for Synovial Sarcoma Biology and Therapeutics
|
1U54CA231638-01
|
$5,251,652
|
KADOCH, CIGALL
|
DANA-FARBER CANCER INST
|
|
Misassembled BAF complexes in human cancer: structural and functional consequences
|
5F31CA196218-04
|
$30,185
|
POYNTER, STEVEN
|
DANA-FARBER CANCER INST
|
|
The Center for Therapeutic Targeting of EWS-oncoproteins
|
1U54CA231637-01
|
$12,500,000
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
|
3R01CA204915-02S1
|
$228,600
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
|
3R01CA204915-02S2
|
$40,302
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics
|
5R01CA204915-02
|
$396,547
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer
|
5R35CA210030-03
|
$1,046,441
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Development of Near-Infrared Molecular Surgical Imaging for Sarcoma Margin Definition
|
5R03CA219445-02
|
$81,000
|
HENDERSON, ERIC
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-39S1
|
$100,606
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-39S2
|
$127,198
|
LEACH, STEVEN
|
DARTMOUTH COLLEGE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|